Long-term follow up of systemic rituximab therapy as first-line and salvage therapy for idiopathic orbital inflammation and review of the literature.

Abou-Hanna, Jacob J; Tiu Teo, Honeylen M; Thangavel, Rajarathna; Elner, Victor M; Demirci, Hakan

Abou-Hanna, Jacob J; Tiu Teo, Honeylen M; Thangavel, Rajarathna; Elner, Victor M; Demirci, Hakan.

Afiliación

Abou-Hanna JJ; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Tiu Teo HM; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Thangavel R; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Elner VM; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Demirci H; Department of Ophthalmology and Visual Science, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.

Orbit ; 41(3): 297-304, 2022 Jun.

Article en En | MEDLINE | ID: mdl-33478316

Asunto(s)

Seudotumor Orbitario; Terapia Recuperativa; Anciano; Estudios de Seguimiento; Humanos; Inflamación/tratamiento farmacológico; Persona de Mediana Edad; Seudotumor Orbitario/diagnóstico; Rituximab/uso terapéutico

Palabras clave

Corticosteroids; first line therapy; idiopathic orbital inflammation; orbital pseudotumor; rituxan; rituximab; salvage therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Recuperativa / Seudotumor Orbitario Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Aged / Humans / Middle aged Idioma: En Revista: Orbit Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google